TMIGD2 Antibody [8A1]

TMIGD2 Antibody [8A1] | RF16121 | ProSci

Host: Mouse

Reactivity: Human

Homology: N/A

Immunogen: TMIGD2 antibody was raised against the extracellular domain of human TMIGD2

Research Area: Immunology, Stem Cell

Tested Application: E, WB, ICC, IF, IHC-P, Flow

Application: TMIGD2 antibody can be used for ELISA starting at 0.25 μg/mL. For Western blot start at 0.25 μg/mL. For Immunocytochemistry start at 2 μg/mL. For Immunofluorescence start at 20 μg/mL. For Immunohistochemistry start at 5 μg/mL. For Flow Cytometry start at 10 μg/ml.

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: Predicted: 28 kDa
Observed: 28 kDa

Validation: N/A

Isoform: N/A

Purification: TMIGD2 Antibody is supplied as protein A purified IgG1.

Clonality: Monoclonal

Clone: 8A1

Isotype: IgG1, k

Conjugate: Unconjugated

Physical State: Liquid

Buffer: TMIGD2 Antibody is supplied in PBS containing 0.02% sodium azide and 50% glycerol.

Concentration: 1 mg/mL

Storage Condition: TMIGD2 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Alternate Name: IGPR1, IGPR-1, IGPR1, UNQ3059/PRO9879, Transmembrane and immunoglobulin domain-containing protein 2, Immunoglobulin and proline-rich receptor CD28 homolog, CD28H

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: TMIGD2 Antibody: TMIGD2 (transmembrane and immunoglobulin domain containing 1) , also known as immunoglobulin-containing and proline-rich receptor 1 (IGPR1) , is novel adhesion molecule that is expressed in multiple tissues, primarily in cells of epithelium and endothelium origins (1) . TMIGD2 is thought to be involved in angiogenesis and regulates cellular morphology, homophilic cell aggregation, and cell-cell interaction. TMIGD2 activity also modulates actin stress fiber formation and focal adhesion and reduces cell migration.